ValiRx - Signs Service Agreement with TheoremRx
VAL
Wed, 05 Jan 2022, 12:00 GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr Suzy Dilly, CEO of ValiRx discusses the Service Agreement with TheoremRx and what it means for Val 201 and the Company. The signature of the agreement formalises the work that has been done and demonstrates the confidence ValiRx has in the sub-license being fully executed in due course.
